SCHEMBL17978906

SCHEMBL17978906

O=C(Oc1ccc(Br)cn1)N1CCNCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 1/20 0.40
▸ NPC1 O15118 1/20 0.39
▸ LMNA P02545 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ ATM Q13315 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ TDP1 Q9NUW8 1/20 0.39
▸ L3MBTL1 Q9Y468 1/20 0.39
▸ LIPE Q05469 5/20 0.38
▸ BCHE P06276 1/20 0.38
▸ GPR183 P32249 4/20 0.37
▸ KCNH2 Q12809 3/20 0.37
▸ SCN7A Q01118 2/20 0.37
▸ SCN9A Q15858 2/20 0.37
▸ TPSAB1 Q15661 1/20 0.37
▸ TPSD1 Q9BZJ3 1/20 0.37
▸ TPSG1 Q9NRR2 1/20 0.37
▸ AKR1C3 P42330 1/20 0.36
▸ SIGMAR1 Q99720 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25315094 0.83 HRH3 (0.40) HRH3LIPEBCHEKCNH2SCN7A
SCHEMBL26633220 0.83 SCN9A (0.52) HRH3LIPEBCHEKCNH2SCN7A
SCHEMBL30117294 0.82 CYP4F2 (0.43) HRH3SMN1; SMN2GPR183KCNH2SCN7A
SCHEMBL30117296 0.82 CYP4F2 (0.43) HRH3SMN1; SMN2GPR183KCNH2SCN7A
SCHEMBL18281398 0.81 TPSAB1 (0.36) HRH3NPC1LMNAMAPTRAB9A
SCHEMBL20476683 0.80 TSHR (0.33) HRH3GPR183KCNH2SCN9AAKR1C3
SCHEMBL25313199 0.79 ALDH1A1 (0.44) LMNAMAPTTDP1KCNH2KDM4E
SCHEMBL17979079 0.77 REN (0.36) HRH3NPC1LMNAMAPTRAB9A
SCHEMBL18343850 0.77 SCN9A (0.38) NPC1LMNAMAPTRAB9AATM
SCHEMBL19717800 0.77 SCN7A (0.47) SMN1; SMN2L3MBTL1KCNH2SCN7ASIGMAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023104111-A1 FUSED HETEROCYCLIC COMPOUNDS AS PI3KALPHA INHIBITORS NANJING ZENSHINE PHARMACEUTICALS CO., LTD. (CN) 2023-06-15 — — WO disclosed
WO-2016192657-A1 SUBSTITUTED PIPERAZINE COMPOUNDS AND METHODS OF USE AND USE THEREOF SUNSHINE LAKE PHARMA CO., LTD. (CN) 2016-12-08 — — WO disclosed
WO-2016127358-A1 INHIBITORS OF RENAL OUTER MEDULLARY POTASSIUM CHANNEL MERCK SHARP & DOHME CORP. (US) 2016-08-18 — — WO disclosed
Send feedback